Multiple myeloma is the second most common hematological neoplasm that also affects young patients. The progression-free survival after autologous stem cell transplant has improved with the introduction of several novel agents such as lenalidomide, which may, however, increase the risk of adverse events.
Guerrini, S., Bucalossi, A., CIOFFI SQUITIERI, N., Mazzei, F.G., Volterrani, L., Mazzei, M.A. (2016). Ischemic colitis diagnosed by magnetic resonance imaging during lenalidomide treatment in a patient with relapsed multiple myeloma. TUMORI, 102(Suppl. 2) [10.5301/tj.5000392].
Ischemic colitis diagnosed by magnetic resonance imaging during lenalidomide treatment in a patient with relapsed multiple myeloma
GUERRINI, SUSANNA;CIOFFI SQUITIERI, NEVADA;VOLTERRANI, LUCA;MAZZEI, MARIA ANTONIETTA
2016-01-01
Abstract
Multiple myeloma is the second most common hematological neoplasm that also affects young patients. The progression-free survival after autologous stem cell transplant has improved with the introduction of several novel agents such as lenalidomide, which may, however, increase the risk of adverse events.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/1008938
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo